Abbott Laboratories's Revenue
- Abbott Laboratories's annual revenue was $40.11B in fiscal year 2023. The annual revenue decreased -$3.54B from $43.65B (in 2022) to $40.11B (in 2023), representing a -8.12% year-over-year decline.
- Abbott Laboratories's quarterly revenue was $10.64B in the quarter ending Sep 2024. The quarterly revenue increased $492.00M from $10.14B (in Q3: June 2023) to $10.64B (in Q3: June 2024), representing a 4.85% year-over-year growth.
- The highest annual revenue for Abbott Laboratories was $43.65B in fiscal year 2022.
- The lowest annual revenue was $20.41B in fiscal year 2015.
- The average revenue was $32.51B.
- Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2015 - 2024):
Learn more about Abbott Laboratories's Revenue by Segment and Revenue by Region.
Check out competitors to Abbott Laboratories in a side-by-side comparison.
Explore additional financial metrics for Abbott Laboratories.
Definition of Revenue :
| 2014 | 20247000000.00 |
|---|---|
| 2015 | 20405000000.00 |
| 2016 | 20853000000.00 |
| 2017 | 27390000000.00 |
| 2018 | 30578000000.00 |
| 2019 | 31904000000.00 |
| 2020 | 34608000000.00 |
| 2021 | 43075000000.00 |
| 2022 | 43653000000.00 |
| 2023 | 40109000000.00 |
| Mar 2015 | 4897000000.00 |
|---|---|
| Jun 2015 | 5170000000.00 |
| Sep 2015 | 5150000000.00 |
| Dec 2015 | 5188000000.00 |
| Mar 2016 | 4885000000.00 |
| Jun 2016 | 5333000000.00 |
| Sep 2016 | 5302000000.00 |
| Dec 2016 | 5333000000.00 |
| Mar 2017 | 6335000000.00 |
| Jun 2017 | 6637000000.00 |
| Sep 2017 | 6829000000.00 |
| Dec 2017 | 7589000000.00 |
| Mar 2018 | 7390000000.00 |
| Jun 2018 | 7767000000.00 |
| Sep 2018 | 7656000000.00 |
| Dec 2018 | 7765000000.00 |
| Mar 2019 | 7535000000.00 |
| Jun 2019 | 7979000000.00 |
| Sep 2019 | 8076000000.00 |
| Dec 2019 | 8314000000.00 |
| Mar 2020 | 7726000000.00 |
| Jun 2020 | 7328000000.00 |
| Sep 2020 | 8853000000.00 |
| Dec 2020 | 10701000000.00 |
| Mar 2021 | 10456000000.00 |
| Jun 2021 | 10223000000.00 |
| Sep 2021 | 10928000000.00 |
| Dec 2021 | 11468000000.00 |
| Mar 2022 | 11895000000.00 |
| Jun 2022 | 11257000000.00 |
| Sep 2022 | 10410000000.00 |
| Dec 2022 | 10091000000.00 |
| Mar 2023 | 9747000000.00 |
| Jun 2023 | 9978000000.00 |
| Sep 2023 | 10143000000.00 |
| Dec 2023 | 10241000000.00 |
| Mar 2024 | 9964000000.00 |
| Jun 2024 | 10377000000.00 |
| Sep 2024 | 10635000000.00 |
2023
Abbott Laboratories's annual revenue was $40.11B in fiscal year 2023.
Abbott Laboratories's quarterly revenue was $9.75B(Q1: Mar 2023), $9.98B(Q2: Jun 2023), $10.14B(Q3: Sep 2023), $10.24B(Q4: Dec 2023) in fiscal year 2023.
2022
Abbott Laboratories's annual revenue was $43.65B in fiscal year 2023.
Abbott Laboratories's quarterly revenue was $11.90B(Q1: Mar 2022), $11.26B(Q2: Jun 2022), $10.41B(Q3: Sep 2022), $10.09B(Q4: Dec 2022) in fiscal year 2022.
2021
Abbott Laboratories's annual revenue was $43.08B in fiscal year 2023.
Abbott Laboratories's quarterly revenue was $10.46B(Q1: Mar 2021), $10.22B(Q2: Jun 2021), $10.93B(Q3: Sep 2021), $11.47B(Q4: Dec 2021) in fiscal year 2021.
2020
Abbott Laboratories's annual revenue was $34.61B in fiscal year 2023.
Abbott Laboratories's quarterly revenue was $7.73B(Q1: Mar 2020), $7.33B(Q2: Jun 2020), $8.85B(Q3: Sep 2020), $10.70B(Q4: Dec 2020) in fiscal year 2020.
2019
Abbott Laboratories's annual revenue was $31.90B in fiscal year 2023.
Abbott Laboratories's quarterly revenue was $7.54B(Q1: Mar 2019), $7.98B(Q2: Jun 2019), $8.08B(Q3: Sep 2019), $8.31B(Q4: Dec 2019) in fiscal year 2019.
2018
Abbott Laboratories's annual revenue was $30.58B in fiscal year 2023.
Abbott Laboratories's quarterly revenue was $7.39B(Q1: Mar 2018), $7.77B(Q2: Jun 2018), $7.66B(Q3: Sep 2018), $7.77B(Q4: Dec 2018) in fiscal year 2018.
2017
Abbott Laboratories's annual revenue was $27.39B in fiscal year 2023.
Abbott Laboratories's quarterly revenue was $6.34B(Q1: Mar 2017), $6.64B(Q2: Jun 2017), $6.83B(Q3: Sep 2017), $7.59B(Q4: Dec 2017) in fiscal year 2017.
2016
Abbott Laboratories's annual revenue was $20.85B in fiscal year 2023.
Abbott Laboratories's quarterly revenue was $4.89B(Q1: Mar 2016), $5.33B(Q2: Jun 2016), $5.30B(Q3: Sep 2016), $5.33B(Q4: Dec 2016) in fiscal year 2016.
2015
Abbott Laboratories's annual revenue was $20.41B in fiscal year 2023.
Abbott Laboratories's quarterly revenue was $4.90B(Q1: Mar 2015), $5.17B(Q2: Jun 2015), $5.15B(Q3: Sep 2015), $5.19B(Q4: Dec 2015) in fiscal year 2015.
| 2014 | 0 |
|---|---|
| 2015 | +0.78 |
| 2016 | +2.20 |
| 2017 | +31.35 |
| 2018 | +11.64 |
| 2019 | +4.34 |
| 2020 | +8.48 |
| 2021 | +24.47 |
| 2022 | +1.34 |
| 2023 | -8.12 |
| Q1: Mar 15 | -6.62 |
|---|---|
| Q2: Jun 15 | -6.86 |
| Q3: Sep 15 | 0.90 |
| Q4: Dec 15 | -3.14 |
| Q1: Mar 16 | -0.25 |
| Q2: Jun 16 | 3.15 |
| Q3: Sep 16 | 2.95 |
| Q4: Dec 16 | 2.79 |
| Q1: Mar 17 | 29.68 |
| Q2: Jun 17 | 24.45 |
| Q3: Sep 17 | 28.80 |
| Q4: Dec 17 | 42.30 |
| Q1: Mar 18 | 16.65 |
| Q2: Jun 18 | 17.03 |
| Q3: Sep 18 | 12.11 |
| Q4: Dec 18 | 2.32 |
| Q1: Mar 19 | 1.96 |
| Q2: Jun 19 | 2.73 |
| Q3: Sep 19 | 5.49 |
| Q4: Dec 19 | 7.07 |
| Q1: Mar 20 | 2.53 |
| Q2: Jun 20 | -8.16 |
| Q3: Sep 20 | 9.62 |
| Q4: Dec 20 | 28.71 |
| Q1: Mar 21 | 35.34 |
| Q2: Jun 21 | 39.51 |
| Q3: Sep 21 | 23.44 |
| Q4: Dec 21 | 7.17 |
| Q1: Mar 22 | 13.76 |
| Q2: Jun 22 | 10.11 |
| Q3: Sep 22 | -4.74 |
| Q4: Dec 22 | -12.01 |
| Q1: Mar 23 | -18.06 |
| Q2: Jun 23 | -11.36 |
| Q3: Sep 23 | -2.56 |
| Q4: Dec 23 | 1.49 |
| Q1: Mar 24 | 2.23 |
| Q2: Jun 24 | 4.00 |
| Q3: Sep 24 | 4.85 |
2023
Abbott Laboratories’s annual revenue decreased -8.12% during fiscal year 2023 compared to 2022. It represents a decline of -$3.54B from $43.65B (in 2022) to $40.11B (in 2023).
2022
Abbott Laboratories’s annual revenue increased +1.34% during fiscal year 2022 compared to 2021. It represents a growth of $578.00M from $43.08B (in 2021) to $43.65B (in 2022).
2021
Abbott Laboratories’s annual revenue increased +24.47% during fiscal year 2021 compared to 2020. It represents a growth of $8.47B from $34.61B (in 2020) to $43.08B (in 2021).
2020
Abbott Laboratories’s annual revenue increased +8.48% during fiscal year 2020 compared to 2019. It represents a growth of $2.70B from $31.90B (in 2019) to $34.61B (in 2020).
2019
Abbott Laboratories’s annual revenue increased +4.34% during fiscal year 2019 compared to 2018. It represents a growth of $1.33B from $30.58B (in 2018) to $31.90B (in 2019).
2018
Abbott Laboratories’s annual revenue increased +11.64% during fiscal year 2018 compared to 2017. It represents a growth of $3.19B from $27.39B (in 2017) to $30.58B (in 2018).
2017
Abbott Laboratories’s annual revenue increased +31.35% during fiscal year 2017 compared to 2016. It represents a growth of $6.54B from $20.85B (in 2016) to $27.39B (in 2017).
2016
Abbott Laboratories’s annual revenue increased +2.20% during fiscal year 2016 compared to 2015. It represents a growth of $448.00M from $20.41B (in 2015) to $20.85B (in 2016).
2015
Abbott Laboratories’s annual revenue increased +0.78% during fiscal year 2015 compared to 2014. It represents a growth of $158.00M from $20.25B (in 2014) to $20.41B (in 2015).
Summary Table (Annual)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| 2023 | $40.11B | -8.12% |
| 2022 | $43.65B | +1.34% |
| 2021 | $43.08B | +24.47% |
| 2020 | $34.61B | +8.48% |
| 2019 | $31.90B | +4.34% |
| 2018 | $30.58B | +11.64% |
| 2017 | $27.39B | +31.35% |
| 2016 | $20.85B | +2.20% |
| 2015 | $20.41B | +0.78% |
Summary Table (Quarterly)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| Q3: Sep 24 | $10.64B | 4.85% |
| Q2: Jun 24 | $10.38B | 4.00% |
| Q1: Mar 24 | $9.96B | 2.23% |
| Q4: Dec 23 | $10.24B | 1.49% |
| Q3: Sep 23 | $10.14B | -2.56% |
| Q2: Jun 23 | $9.98B | -11.36% |
| Q1: Mar 23 | $9.75B | -18.06% |
| Q4: Dec 22 | $10.09B | -12.01% |
| Q3: Sep 22 | $10.41B | -4.74% |
| Q2: Jun 22 | $11.26B | 10.11% |
| Q1: Mar 22 | $11.90B | 13.76% |
| Q4: Dec 21 | $11.47B | 7.17% |
| Q3: Sep 21 | $10.93B | 23.44% |
| Q2: Jun 21 | $10.22B | 39.51% |
| Q1: Mar 21 | $10.46B | 35.34% |
| Q4: Dec 20 | $10.70B | 28.71% |
| Q3: Sep 20 | $8.85B | 9.62% |
| Q2: Jun 20 | $7.33B | -8.16% |
| Q1: Mar 20 | $7.73B | 2.53% |
| Q4: Dec 19 | $8.31B | 7.07% |
| Q3: Sep 19 | $8.08B | 5.49% |
| Q2: Jun 19 | $7.98B | 2.73% |
| Q1: Mar 19 | $7.54B | 1.96% |
| Q4: Dec 18 | $7.77B | 2.32% |
| Q3: Sep 18 | $7.66B | 12.11% |
| Q2: Jun 18 | $7.77B | 17.03% |
| Q1: Mar 18 | $7.39B | 16.65% |
| Q4: Dec 17 | $7.59B | 42.30% |
| Q3: Sep 17 | $6.83B | 28.80% |
| Q2: Jun 17 | $6.64B | 24.45% |
| Q1: Mar 17 | $6.34B | 29.68% |
| Q4: Dec 16 | $5.33B | 2.79% |
| Q3: Sep 16 | $5.30B | 2.95% |
| Q2: Jun 16 | $5.33B | 3.15% |
| Q1: Mar 16 | $4.89B | -0.25% |
| Q4: Dec 15 | $5.19B | -3.14% |
| Q3: Sep 15 | $5.15B | 0.90% |
| Q2: Jun 15 | $5.17B | -6.86% |
| Q1: Mar 15 | $4.90B | -6.62% |
Related
-
Agilent Technologies Revenue
-
Eli Lilly and Company Revenue
-
Stryker Corporation Revenue
-
Johnson & Johnson Revenue
-
AbbVie Revenue
-
Merck & Co. Revenue
-
Thermo Fisher Scientific Revenue
-
Danaher Corporation Revenue
-
Amgen Revenue
-
Pfizer Revenue
-
Boston Scientific Corporation Revenue
-
Bristol-Myers Squibb Company Revenue
-
Cigna Corporation Revenue
-
McKesson Corporation Revenue
-
Cardinal Health Revenue
-
Moderna Revenue
